NMS Capital has exited its investment in Flourish Research, a US-based clinical trial organization, through a sale to Genstar Capital. No financial terms were disclosed.

Original research ranges from new concepts in human biology and disease pathogenesis to new therapeutic modalities and drug development, to all phases of clinical work, as well as innovative ...

LifeSci Capital analyst Anshul Dhankher maintained a Buy rating on Perspective Therapeutics (CATX – Research ... clinical programs, specifically with VMT-alpha-NET and VMT-01, which target specific ...

For instance, AI algorithms can rapidly screen millions of compounds, significantly speeding up the initial phases of drug ...

Tetanus is a serious bacterial infection caused by Clostridium tetani, which affects the nervous system, leading to muscle stiffness and spasms. With an increased awareness of disease prevention, ...

Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...

Experts have identified a cannabis compound called cannabinol (CBN) that appears to significantly enhance sleep quality.

BioDuro-Sundia opens new kilogram laboratory at Shanghai to speed development from discovery to preclincal and clinical ...

"We identified two main phases in AD by arranging donors along ... with no symptoms to advanced dementia cases. "By studying research subjects across the spectrum of AD, including those in the ...

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2024. Today, Nov. 12, 2024, the moon is 11 days old and is in the Waxing Gibbous phase of its lunar ...